Most unusual share price action one could ever expect after a massive profit upgrade. Share price hardly rises and then drops.
what gives???????
COVID testing numbers appear to have stabilised and appear likely stay higher than most expect.
November and December forecast contains very little of this additional testing. I'd be surprised if profits don't top $100m and possibly could go as high as $130m for the first half. So somewhere between $100m and $130m.
COVID is not going away(yet). So testing will continue very similar to flu longer term.
Anyone with any ideas as to why it is not trading higher?
News: ACL Australian Clinical Labs Sees H1 Revenue of A$437.5 Mln-A$454.9 Mln, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.82 |
Change
-0.010(0.35%) |
Mkt cap ! $553.8M | |||
| Open | High | Low | Value | Volume |
| $2.83 | $2.83 | $2.78 | $1.879M | 670.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1071 | $2.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 2376 | 2 |
View Market Depth
| Last trade - 16.14pm 29/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |